Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257202 · ClinicalTrials.gov registry record · Phase 2
Topical Treatment and Prevalence of P. Acnes
A Phase 2 study of Surgical Site Infection, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03257202: Completed Phase 2 study of Surgical Site Infection, sponsored by University of Southern California.
NCT03257202 is a Phase 2 study of Surgical Site Infection that has completed, run by University of Southern California. The registered enrollment target is 12 participants, below the 568-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03257202, a Phase 2 study of Surgical Site Infection, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about preventing surgical site infections of the shoulder. We hope to learn if clindamycin alone, benzoyl peroxide alone, or clindamycin and benzoyl peroxide together can affect growth of Propionibacterium acnes in the dermal layer.
Primary Outcome
Detected presence of growth of Propionibacterium acnes on bacterial culture (bacteria per mL) by treatment arms.
Conditions Studied
Interventions
- DRUG Clindamycin 1% Gel
- DRUG Benzoyl peroxide 5% gel
- DRUG BenzaClin 5%-1% Topical Gel
Study Locations (1)
California
- Keck School of Medicine of the University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2018-01-01 |
| Phase | Phase 2 |
What the finished NCT03257202 record still lists
NCT03257202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 568-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Surgical Site Infection appearing as the primary indexed condition, and to 3 interventions - of which Clindamycin 1% Gel is the first listed.
NCT03257202 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03257202 about?
NCT03257202 is a clinical study titled "Topical Treatment and Prevalence of P. Acnes". This study is about preventing surgical site infections of the shoulder. We hope to learn if clindamycin alone, benzoyl peroxide alone, or clindamycin and benzoyl peroxide together can affect growth of Propionibacterium acnes in the dermal layer.
What is the current status of trial NCT03257202?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2017-09-11. Estimated completion is 2018-01-01.
What conditions does trial NCT03257202 study?
This clinical trial studies the following conditions: Surgical Site Infection.
What interventions are being tested in trial NCT03257202?
The interventions under investigation include: Clindamycin 1% Gel (DRUG), Benzoyl peroxide 5% gel (DRUG), BenzaClin 5%-1% Topical Gel (DRUG).
Who is sponsoring clinical trial NCT03257202?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03257202 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03257202's enrollment target sits among peer trials
12 26th of 25 the lowest of 25 other Surgical Site Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
COMPLETED · Phase 2
-
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)
COMPLETED · Phase 2
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
RECRUITING · Phase 3
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI